TrialEuropean urology2021
Efficacy and Safety of Cabazitaxel Versus Abiraterone or Enzalutamide in Older Patients with Metastatic Castration-resistant Prostate Cancer in the CARD Study.
Cora N Sternberg et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
14 papers cite it
this paperpooled itcites it